Analisi molecolare della malattia midollare ed ematica in pazienti affetti da neuroblastoma

Maria Valeria Corrias(Boston Children's Hospital), Vito Pistoia(Istituto Giannina Gaslini), Marzia Occhino(Istituto Giannina Gaslini), Paola Scaruffi(Azienda Ospedaliera S.Maria)

Unknown

January 1, 2001

Cited by 0

Related Papers

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

|The Lancet Oncology|2009|196

Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing <i>in vitro</i> fertilization

|Gynecological Endocrinology|2019|188

Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation

|Human Reproduction|2013|172

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

|Journal of Clinical Oncology|2010|130

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

|Journal of Clinical Oncology|1997|113